Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long‐Term Survival

Amirhossein Azhie,Priya Sheth,Ahmed Hammad,Minna Woo,Mamatha Bhat
DOI: https://doi.org/10.1002/lt.26219
2021-07-31
Liver Transplantation
Abstract:Liver transplant (LT) recipients have experienced a significant improvement in short-term survival during the last three decades due to advancements in surgical techniques, perioperative management and effective immunosuppressive regimens. However, long-term survival is affected by a high incidence of metabolic disorders and their consequences including cardiovascular disease and malignancies. Pre-transplant metabolic impairments especially in those with NASH cirrhosis are aggravated by addition of post-transplant weight gain, physical inactivity, and reversal from catabolic to anabolic state. Moreover, although immunosuppressants are vital to avoid graft rejection, long term exposure to these medications is implicated in metabolic impairments post-LT. In this review, we aim to summarize molecular pathogenesis of different metabolic disorders post-LT including diabetes mellitus, dyslipidemia, and non-alcoholic fatty liver disease. Furthermore, cardiovascular disease, malignancies, and graft rejections were provided as significant complications of post-LT metabolic conditions threatening both patient and graft survival. Ultimately, emerging preventive and treatment strategies for post-transplant diabetes mellitus are summarized. This review highlighted the significant need for more clinical trials of antihyperglycemic agents in LT recipients. Also, translational studies will help us to better understand the molecular and genetic factors underlying these metabolic complications and could lead to a more personalized management in this high-risk population.
gastroenterology & hepatology,surgery,transplantation
What problem does this paper attempt to address?